Skip to content

A clinical trial to study the effect of patolanimbapatra arka and triphala kwatha in leg ulcer.

A comparative study on the antimicrobial effect of patolanimbapatra arka against triphala kwatha in leg ulcer. - Not applicable

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/05/052401
Enrollment
36
Registered
2023-05-09
Start date
Unknown
Completion date
Unknown
Last updated
2023-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L99- Other disorders of skin and subcutaneous tissue in diseases classified elsewhere

Interventions

None listed

Sponsors

Government Ayurveda College Tripunithura Ernakulam
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Subjects diagnosed with leg ulcers with slough and discharge. • Venous ulcer • Arterial ulcer • Diabetic foot ulcer • Ulcer size within 10 x 10 cm • Ulcers involving skin and muscle only Subjects within the age group 20-70 years. Subjects will be selected irrespective of gender, religion, caste and economic status. Subjects with written informed consent will only be selected.

Exclusion criteria

Exclusion criteria: Leg ulcers with known cases of: - 1. Tuberculosis 2. Malignancy 3. Burns 4.Gangrene 5.Traumatic ulcer (within 7 days)

Design outcomes

Primary

MeasureTime frame
Assessment of antimicrobial effect by reduction in microbial load assessed by gradingTimepoint: assessment on 0th and 8th day

Secondary

MeasureTime frame
1.Reduction in discharge assessed by grading 2. Reduction in pain assessed by grading 3. Reduction in odour assessed by grading 4. Formation of granulation tissue assessed by gradingTimepoint: assessment on 0th 4th and 8th day

Countries

India

Contacts

Public ContactDr Subi N H MS Ay

Government Ayurveda College Tripunithura Ernakulam

drsubironish@gmail.com9074212705

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026